TIE1

Chr 1AD

tyrosine kinase with immunoglobulin like and EGF like domains 1

Also known as: JTK14, LMPHM11, TIE

This gene encodes a transmembrane tyrosine kinase that regulates angiogenesis and blood vessel stability by inhibiting angiopoietin 1 signaling through the endothelial receptor tyrosine kinase Tie2. Mutations cause lymphatic malformation 11, a vascular malformation disorder that follows autosomal dominant inheritance. The condition primarily affects the lymphatic vascular system, resulting in abnormal lymphatic vessel development and function.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismADLOEUF 0.891 OMIM phenotype
Clinical SummaryTIE1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
13 unique Pathogenic / Likely Pathogenic· 175 VUS of 220 total submissions
Some data sources returned errors (1)

opentargets: TimeoutError: The operation was aborted due to timeout

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.89LOEUF
pLI 0.000
Z-score 2.27
OE 0.68 (0.520.89)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.51Z-score
OE missense 0.84 (0.790.90)
615 obs / 729.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.68 (0.520.89)
00.351.4
Missense OE0.84 (0.790.90)
00.61.4
Synonymous OE0.89
01.21.6
LoF obs/exp: 39 / 57.6Missense obs/exp: 615 / 729.9Syn Z: 1.53
DN
0.7131th %ile
GOF
0.75top 25%
LOF
0.2874th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

220 submitted variants in ClinVar

Classification Summary

Pathogenic12
Likely Pathogenic1
VUS175
Likely Benign9
Benign4
12
Pathogenic
1
Likely Pathogenic
175
VUS
9
Likely Benign
4
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
2
10
0
12
Likely Pathogenic
0
0
1
0
1
VUS
2
168
5
0
175
Likely Benign
0
4
1
4
9
Benign
0
0
0
4
4
Total2174178201

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TIE1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →